Hypertrophic Cardiomyopathy and Left Ventricular Non-Compaction

[1]  Matthew W. Martinez,et al.  2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[2]  Kristen L. Kucera,et al.  Aetiology and incidence of sudden cardiac arrest and death in young competitive athletes in the USA: a 4-year prospective study , 2020, British Journal of Sports Medicine.

[3]  G. T. Gunnarsson,et al.  2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. , 2020, European heart journal.

[4]  M. Bonifazi,et al.  Prescribing, dosing and titrating exercise in patients with hypertrophic cardiomyopathy for prevention of comorbidities: Ready for prime time. , 2020, European Journal of Preventive Cardiology.

[5]  C. Autore,et al.  Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study , 2020, British Journal of Sports Medicine.

[6]  B. Maron,et al.  Hypertrophic Cardiomyopathy and Sudden Death Initially Identified at Autopsy. , 2020, The American journal of cardiology.

[7]  E. Behr,et al.  Sudden Death Can Be the First Manifestation of Hypertrophic Cardiomyopathy: Data From a United Kingdom Pathology Registry. , 2019, JACC. Clinical electrophysiology.

[8]  H. Heidbuchel,et al.  Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). , 2018, European heart journal.

[9]  D. Ramsdale,et al.  Outcomes of Cardiac Screening in Adolescent Soccer Players , 2018, The New England journal of medicine.

[10]  S. Caselli,et al.  Does Sport Participation Worsen the Clinical Course of Hypertrophic Cardiomyopathy? Clinical Outcome of Hypertrophic Cardiomyopathy in Athletes. , 2018, Circulation.

[11]  R. Chan,et al.  Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.

[12]  V. Berti,et al.  Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  J. Skinner,et al.  A Prospective Study of Sudden Cardiac Death among Children and Young Adults. , 2016, The New England journal of medicine.

[14]  E. Behr,et al.  Etiology of Sudden Death in Sports: Insights From a United Kingdom Regional Registry. , 2016, Journal of the American College of Cardiology.

[15]  S. Caselli,et al.  Left Ventricular Noncompaction Diagnosis and Management Relevant to Pre-participation Screening of Athletes. , 2015, The American journal of cardiology.

[16]  J. Towbin,et al.  Left ventricular non-compaction cardiomyopathy , 2015, The Lancet.

[17]  M. Ackerman,et al.  Original Research Put Into Perspective for the Practicing Clinician Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A Decade in Review , 2015 .

[18]  Mathew G. Wilson,et al.  See Clinical Perspective , 2022 .

[19]  D. Bluemke,et al.  The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study. , 2014, Journal of the American College of Cardiology.

[20]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[21]  Giuseppe Limongelli,et al.  A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.

[22]  E. Cook,et al.  Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.

[23]  Mathew G. Wilson,et al.  Incidence of sudden cardiac death in athletes: a state-of-the-art review , 2014, Heart.

[24]  B. Maron,et al.  Incidence and causes of sudden death in U.S. college athletes. , 2014, Journal of the American College of Cardiology.

[25]  M. Link,et al.  Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry. , 2013, Circulation.

[26]  Matt Reed,et al.  Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? , 2013, Heart.

[27]  I. Olivotto,et al.  Microvascular Dysfunction, Myocardial Ischemia, and Progression to Heart Failure in Patients with Hypertrophic Cardiomyopathy , 2009, Journal of cardiovascular translational research.

[28]  Barry J Maron,et al.  The case for myocardial ischemia in hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[29]  B. Maron,et al.  Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2009, Circulation.

[30]  P. Elliott,et al.  Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy. , 2006, European heart journal.

[31]  F. Girolami,et al.  Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[32]  Michael J Ackerman,et al.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. , 2004, Circulation.

[33]  P. Elliott,et al.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.

[34]  B. Maron,et al.  Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy , 2016 .

[35]  C. Tracy,et al.  Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. , 1987, Journal of the American College of Cardiology.

[36]  T. Edvardsen,et al.  Vigorous exercise in patients with hypertrophic cardiomyopathy. , 2018, International journal of cardiology.